Qatar Authorizes Moderna's COVID-19 Vaccine

Massachusetts-based Moderna, Inc. announced on February 11, 2021, the Qatar Ministry of Public Health had issued an emergency use authorization for COVID-19 Vaccine Moderna. The approval is based on the totality of scientific evidence shared by the Company, including a data analysis from the pivotal Phase 3 clinical study announced on November 30. 

Qatar has secured COVID-19 Vaccine Moderna access through a supply agreement announced on October 26, 2020.

“I want to thank the Qatar Ministry of Public Health for this authorization, which marks an important step forward in the global fight against COVID-19. We appreciate their continued confidence in our mRNA vaccine,” commented Stéphane Bancel, Chief Executive Officer of Moderna, in a press statement.

The Moderna COVID-19 Vaccine (mRNA-1273) is an mRNA vaccine candidate against the novel coronavirus SARS-CoV-2 encoding for a prefusion stabilized form of the Spike protein selected by Moderna in collaboration with investigators NIAID Vaccine Research Center.

Moderna has previously received authorization for its COVID-19 vaccine from health agencies in the United States, Canada, Israel, the European Union, the United Kingdom, Switzerland, and Singapore.